46 related articles for article (PubMed ID: 27400900)
1. Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy.
Mentias A; Heller E; Vaughan Sarrazin M
Stroke; 2020 Jul; 51(7):2076-2086. PubMed ID: 32517580
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban-Induced Hemorrhage Associated with
Ing Lorenzini K; Daali Y; Fontana P; Desmeules J; Samer C
Front Pharmacol; 2016; 7():494. PubMed ID: 28066243
[TBL] [Abstract][Full Text] [Related]
3. Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
Imprialos K; Boutari C; Stavropoulos K
Circulation; 2016 Jul; 134(2):e5-6. PubMed ID: 27400901
[No Abstract] [Full Text] [Related]
4. Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
Piccini JP; Hellkamp AS; Washam JB; Becker RC; Breithardt G; Berkowitz SD; Halperin JL; Hankey GJ; Hacke W; Mahaffey KW; Nessel CC; Singer DE; Fox KA; Patel MR
Circulation; 2016 Jul; 134(2):e7-8. PubMed ID: 27400902
[No Abstract] [Full Text] [Related]
5. Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation.
Piccini JP; Hellkamp AS; Washam JB; Becker RC; Breithardt G; Berkowitz SD; Halperin JL; Hankey GJ; Hacke W; Mahaffey KW; Nessel CC; Singer DE; Fox KA; Patel MR
Circulation; 2016 Jan; 133(4):352-60. PubMed ID: 26673560
[TBL] [Abstract][Full Text] [Related]
6. Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients.
Laliberté F; Cloutier M; Nelson WW; Coleman CI; Pilon D; Olson WH; Damaraju CV; Schein JR; Lefebvre P
Curr Med Res Opin; 2014 Jul; 30(7):1317-25. PubMed ID: 24650301
[TBL] [Abstract][Full Text] [Related]
7. The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naïve, new-onset nonvalvular atrial fibrillation.
Hurley C; Dai S; Sobieraj DM
Int J Cardiol; 2015 Aug; 192():1-2. PubMed ID: 25981569
[No Abstract] [Full Text] [Related]
8. Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
Bouatou Y; El Biali M; Samer CF
Circulation; 2016 Jul; 134(2):e3-4. PubMed ID: 27400900
[No Abstract] [Full Text] [Related]
9. The efficacy of rivaroxaban in patients with atrial fibrillation.
Carag MR; Arora RR
Am J Ther; 2014; 21(5):412-8. PubMed ID: 22487774
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban and stroke prevention in patients with atrial fibrillation: new evidence.
Martínez-Rubio A; Dan GA; Kaski JC
Expert Rev Cardiovasc Ther; 2014 Aug; 12(8):933-47. PubMed ID: 24948333
[TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice.
Barón-Esquivias G; Marín F; Sanmartín Fernandez M
Expert Rev Cardiovasc Ther; 2017 May; 15(5):403-413. PubMed ID: 28319424
[TBL] [Abstract][Full Text] [Related]
12. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
